Genetix products include ClonePix and QPix instrument platforms which are designed to address cell lines used in biotherapeutic research.
ClonePix is an automated mammalian cell selection platform that expedites the process of identifying and selecting cells that produce biotherapeutic candidates.
Molecular Devices president Mark Verheyden said they are excited about welcoming Genetix into the Molecular Devices team, knowing that the combined business will better positioned to serve their customers.